Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Christian Winther Eskelund"'
Autor:
Anna Sandström Gerdtsson, Joana de Matos Rodrigues, Christian Winther Eskelund, Simon Husby, Kirsten Grønbæk, Riikka Räty, Arne Kolstad, Christian Geisler, Anna Porwit, Mats Jerkeman, Sara Ek
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
The variable outcome to standard immunochemotherapy for mantle cell lymphoma (MCL) patients is a clinical challenge. Established risk factors, including high MCL International Prognostic Index (MIPI), high proliferation (Ki-67), non-classic (blastoid
Externí odkaz:
https://doaj.org/article/fd3814cc49814ec6ad284198f9418857
Autor:
Lavanya Lokhande, Venera Kuci Emruli, Christian Winther Eskelund, Arne Kolstad, Martin Hutchings, Riikka Räty, Carsten Utoft Niemann, Kirsten Grønbæk, Mats Jerkeman, Sara Ek
Publikováno v:
Cancer Reports, Vol 5, Iss 7, Pp n/a-n/a (2022)
Abstract Background The possibility to monitor patient's serum proteome during treatment can provide deepened understanding of the biology associated with response to specific drugs. Non‐invasive serum sampling provides an opportunity for sustainab
Externí odkaz:
https://doaj.org/article/7631cd50529f493cbd46cd934cda28fd
Autor:
Christian Winther Eskelund, Kostas Dimopoulos, Arne Kolstad, Ingrid Glimelius, Riikka Räty, Lise Mette Rahbek Gjerdrum, Kristina Sonnevi, Pär Josefsson, Herman Nilsson-Ehle, Hans H. N. Bentzen, Unn Merete Fagerli, Outi Kuittinen, Jacob Haaber, Carsten Utoft Niemann, Lone Bredo Pedersen, Maria Torp Larsen, Christian Hartmann Geisler, Martin Hutchings, Mats Jerkeman, Kirsten Grønbæk
Publikováno v:
HemaSphere, Vol 5, Iss 1, p e510 (2021)
Mantle cell lymphoma (MCL) is an incurable disease with a highly variable clinical course. The prognosis after relapse is generally poor, and no standard of care exists. We investigated the postrelapse outcomes of 149 patients who were initially trea
Externí odkaz:
https://doaj.org/article/f30a67801c4541d3800f781622702ede
Autor:
Catja Freiburghaus, Venera Kuci Emruli, Angelica Johansson, Christian Winther Eskelund, Kirsten Grønbæk, Roger Olsson, Fredrik Ek, Mats Jerkeman, Sara Ek
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-17 (2018)
Abstract Background The addition of high-dose cytarabine to the treatment of mantle cell lymphoma (MCL) has significantly prolonged survival of patients, but relapses are common and are normally associated with increased resistance. To elucidate the
Externí odkaz:
https://doaj.org/article/a48002ef2c2f4595992abace3e2ffc4b
Autor:
Christian Winther Eskelund, Alexandra Albertsson-Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Lone Bredo Pedersen, Christian Hartmann Geisler, Mats Jerkeman, Kirsten Grønbæk
Publikováno v:
Haematologica, Vol 103, Iss 11 (2018)
Externí odkaz:
https://doaj.org/article/010fd38a51c04e03a49a39f12c42a243
Autor:
Ruth Salim, Simon Husby, Christian Winther Eskelund, David W. Scott, Harald Holte, Arne Kolstad, Riikka Räty, Sara Ek, Mats Jerkeman, Christian H. Geisler, Lasse Sommer Kristensen, Mette Dahl, Kirsten Grønbæk
Publikováno v:
Blood. 140:9254-9256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::146cce93beca48be6f8b41b543621b51
https://doi.org/10.1182/blood-2022-159472
https://doi.org/10.1182/blood-2022-159472
Autor:
Francesco Favero, Kirsten Grønbæk, Lone Bredo Pedersen, Arne Kolstad, Christian Winther Eskelund, Joachim Weischenfeldt, Simon Husby, Mats Jerkeman, Christian H. Geisler, F.G. Rodriguez‐Gonzalez, Riikka Räty, Tobias Wirenfeldt Klausen
Publikováno v:
Blood. 135:2000-2004
Eskelund et al examined clonal hematopoiesis (CH) in a cohort of patients with mantle cell lymphoma (MCL) treated with first-line chemotherapy and autologous stem cell transplantation. In young, good-risk MCL patients, CH after first-line therapy ari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edc3c8e44543e588ec6de21fecb2aeab
https://doi.org/10.1182/blood.2019003539
https://doi.org/10.1182/blood.2019003539
Autor:
Alexandra Albertsson-Lindblad, Christian Winther Eskelund, Åsa Lindberg, Arne Kolstad, Christian H. Geisler, Kirsten Grønbæk, Riikka Räty, Anna Laurell, Mats Jerkeman
Publikováno v:
Lindberg, Å, Eskelund, C W, Albertsson-Lindblad, A, Kolstad, A, Laurell, A, Räty, R, Grønbæk, K, Geisler, C H & Jerkeman, M 2022, ' Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma : The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience ', Hematological Oncology, vol. 40, no. 1, pp. 23-31 . https://doi.org/10.1002/hon.2940
Mantle cell lymphoma (MCL) is a rare, often aggressive type of B-cell lymphoma with poor survival and no cure. Cancer and cancer treatment has a negative impact on health-related quality of life (HRQOL) both during active disease and in the long term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5447dfa3636f368fa37f8a1294d4f8
https://curis.ku.dk/portal/da/publications/pretreatment-healthrelated-quality-of-life-parameters-have-prognostic-impact-in-patients-65years-with-newly-diagnosed-mantle-cell-lymphoma(6355d860-2b80-4a1f-a904-05e5a772f03d).html
https://curis.ku.dk/portal/da/publications/pretreatment-healthrelated-quality-of-life-parameters-have-prognostic-impact-in-patients-65years-with-newly-diagnosed-mantle-cell-lymphoma(6355d860-2b80-4a1f-a904-05e5a772f03d).html
Autor:
Riikka Räty, Kirsten Grønbæk, Mats Jerkeman, Simon Husby, Lasse Sommer Kristensen, Søren Besenbacher, Christian Winther Eskelund, Mette Dahl, Christophe Côme, Christian H. Geisler, Jørgen Kjems, Sara Ek, Arne Kolstad, Søren Fjelstrup
Publikováno v:
Dahl, M, Husby, S, Eskelund, C W, Besenbacher, S, Fjelstrup, S, Côme, C, Ek, S, Kolstad, A, Räty, R, Jerkeman, M, Geisler, C H, Kjems, J, Kristensen, L S & Grønbæk, K 2022, ' Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma : a study of younger patients from the MCL2 and MCL3 clinical trials ', Leukemia, vol. 36, no. 1, pp. 177-188 . https://doi.org/10.1038/s41375-021-01311-4
Mantle cell lymphoma (MCL) is characterized by marked differences in outcome, emphasizing the need for strong prognostic biomarkers. Here, we explore expression patterns and prognostic relevance of circular RNAs (circRNAs), a group of endogenous non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f229182a867e1fa3f9c9b54eee554d2
https://pure.au.dk/portal/da/publications/expression-patterns-and-prognostic-potential-of-circular-rnas-in-mantle-cell-lymphoma(3f0c1823-30cd-4aa2-8933-8ee5a4ec417d).html
https://pure.au.dk/portal/da/publications/expression-patterns-and-prognostic-potential-of-circular-rnas-in-mantle-cell-lymphoma(3f0c1823-30cd-4aa2-8933-8ee5a4ec417d).html
Autor:
null Åsa Lindberg, null Christian Winther Eskelund, null Alexandra Albertsson‐Lindblad, null Arne Kolstad, null Anna Laurell, null Riikka Räty, null Kirsten Grønbæk, null Christian Hartmann Geisler, null Mats Jerkeman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7769f72fef003113031dfe335d1d753
https://doi.org/10.1002/hon.2940/v2/response1
https://doi.org/10.1002/hon.2940/v2/response1